April 5-6, 2021 Webconference

The Longwood Healthcare Leaders meeting, April 5-6, 2021, is centered on MIT’s Koch Institute via webconference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil Sharp

Speakers include Operation Warp Speed Chief Advisor Moncef Slaoui, FDA CDER Director Janet Woodcock, GSK R&D head Hal Barron, Regeneron CSO George Yancopoulos, Janssen Global R&D head Mathai Mammen, Sanofi R&D head John Reed, Genentech CEO Alexander Hardy, Novartis Institutes for BioMedical Research President Jay Bradner, Takeda R&D head Andy Plump, AbbVie Chief Strategy Officer Henry Gosebruch, Merck Chief Patient Officer and former CDC Director Julie Gerberding, BMS R&D head Rupert Vessey, Moderna CSO Melissa Moore, Alexion R&D head John Orloff, AbbVie R&D head Tom Hudson, Amgen R&D head David Reese, BIO Chair Jeremy Levin, Moderna co-founder and Nobelist Bob Langer, Koch MIT Director Tyler Jacks, among others.

These meetings are focused on accelerating the translation of discoveries into medicines to help patients; substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities.

​Longwood Healthcare Leaders meetings are off-the-record without the presence of media. All participants are asked not to post anything shared in discussion to social media. Meetings are currently planned either solely via webconference or predominantly via webconference.

​

Cancellation policy:  If a participant needs to cancel attendance, we are pleased to allow transfer of registration to a colleague or to the next meeting.  In the case of postponement of an event, all registrations will be accepted for a rescheduled or subsequent meeting.

© 2021 Longwood Healthcare Leaders